Right now, the focus of CrushTheStreet.com is to make sure all readers are as UPDATED as possible on the Covid-19 pandemic.
Medical discovery and development can serve a number of beneficial purposes. For humankind, new drugs can treat debilitating conditions and improve people’s quality of life. And for investors who don’t wait too long, a position in cutting-edge science can grow with astounding speed.
Crush the Street saw the earliest signs of life in the medical cannabis market, and we sent out signals on a number of companies in that niche. After booking profits in that market, it’s time to turn our attention to the next class of medical treatments that will go from underappreciated to mainstream.
Over the years, Dr. Roger McIntyre has seen the incredible healing potential that alternative medicine can offer. He’s a world-renowned Professor of Psychiatry and Pharmacology at the University of Toronto, as well as the Head of the Mood Disorders Psychopharmacology Unit at the University Health Network in Toronto.
Notably, Dr. McIntyre also recently accepted the position of Chief Executive Officer at Champignon Brands (CSE:SHRM, OTC:SHRMF). This is a company I’d had on my watch list already, and I actually had the chance to interview Dr. McIntyre to get a sense of the bigger picture in psychedelic-medicine research.
Champignon Brands’ focus is to develop and commercialize rapid-onset treatments capable of improving health outcomes for individuals suffering from depression, post-traumatic stress disorder (PTSD), as well as substance and alcohol-use disorders.
Having dedicated more than 20 years to caring for people with these types of conditions, Dr. McIntyre brings a wealth of knowledge and experience to Champignon Brands. And since the FDA recently approved ketamine for research into treating depression and related mood disorders, Dr. McIntyre and his team at Champignon are moving forward quickly towards novel medical solutions.
93% Of Investors Generate Annual Returns, Which Barely Beat Inflation.
Wealth Education and Investment Principles Are Hidden From Public Database On Purpose!
Build The Knowledge Base To Set Yourself Up For A Wealthy Retirement and Leverage The Relationships We Are Forming With Proven Small-Cap Management Teams To Hit Grand-Slams!
With the company’s world-class, next-generation facilities, Champignon’s research infrastructure sets it apart in what’s already a very small emerging field. Trying to find another company with a CEO like Dr. McIntyre, with the infrastructure already in place and operational, and that’s cash-flow-positive, and is publicly traded, would be practically impossible.
The irony here, as Dr. McIntyre explained in the interview, is that while psychedelics-enhanced medical treatments are just now being properly researched and developed, they’ve actually been around for many years. The problem is that counterculture associations in the 1960’s and 1970’s gave these medicines a bad reputation and thus the government halted the research.
Today, however, this is quickly changing as over 75% of people around the world with depressive disorders are inadequately treated. Society is finally starting to recognize the need for better solutions, and the government is finally granting approval to research into psychedelics’ potential for addressing these mood disorders.
The watershed legal moment, according to Dr. McIntyre, was when the FDA assigned breakthrough status to this class of alternative medicines and allowed the fast-tracking of research into psychedelics as a possible treatment for depression and related conditions.
In the interview, Dr. McIntyre actually breaks down the science and makes it understandable. He also explains SHRM/SHRMF stock’s rare value proposition as Champignon Brands is set to become this niche’s first real hyper-growth company. But for now, you can still own the shares at a ridiculously low valuation before the trading floor bids up this fast mover and burgeoning market leader.
This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.
Never base any decision off of our emails. CrushTheStreet.com stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. You should know that Gold Standard Media LLC, owned by the same parties as Future Money Trends LLC, has been compensated three hundred thousand dollars, directly by the company, for a two year public awareness campaign. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites. Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at CrushTheStreet.com/disclaimer.
Governments Have Amassed ungodly Debt Piles and Have Promised Retirees Unreasonable Amounts of Entitlements, Not In Line with Income Tax Collections. The House of Cards Is Set To Be Worse than 2008! Rising Interest Rates Can Topple The Fiat Monetary Structure, Leaving Investors with Less Than Half of Their Equity Intact!